Cargando…
Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma
BACKGROUND: While dosing theophylline in asthmatics, we should consider that a lot of medicines, substances, conditions and diseases affect the clearance of theophylline, such as smoking, macrolide antibiotics, barbiturates, oral contraceptives, heart and liver insufficiency, alcohol, calcium-antago...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Institute of Immunobiology and Human Genetics
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877906/ https://www.ncbi.nlm.nih.gov/pubmed/27275306 http://dx.doi.org/10.3889/oamjms.2015.117 |
_version_ | 1782433474667347968 |
---|---|
author | Goseva, Zlatica Gjorcev, Angelko Kaeva, Biserka Jovkovska Janeva, Elena Jovanovska Angelovska, Irina |
author_facet | Goseva, Zlatica Gjorcev, Angelko Kaeva, Biserka Jovkovska Janeva, Elena Jovanovska Angelovska, Irina |
author_sort | Goseva, Zlatica |
collection | PubMed |
description | BACKGROUND: While dosing theophylline in asthmatics, we should consider that a lot of medicines, substances, conditions and diseases affect the clearance of theophylline, such as smoking, macrolide antibiotics, barbiturates, oral contraceptives, heart and liver insufficiency, alcohol, calcium-antagonists, pneumonia, viral infections, hypoxemia, etc. AIM: The aim of the study is to investigate the concentrations of theophylline during the day in smoking and nonsmoking patients with asthma. MATERIAL AND METHODS: We have estimated the concentrations of theophylline 6 times daily by the HPLC method (Keith Muir, J Chromatography) in 20 smoking and 20 nonsmoking asthmatic patients, who were treated with theophylline sustained-release tablets 175 mg twice daily. RESULTS: In the first group of 20 nonsmoking patients we obtained constant therapeutic and optimal concentrations of theophylline. In the second group of 20 smoking asthmatics the concentration of theophylline in plasma, in 8pm and 8am the next day was very low. CONCLUSION: Because in smokers we have increased clearance and the decreased half- life of theophylline, and in order to prevent the night time life-threatening attacks, it is necessary to recommend maximal doses of theophylline, especially in the evening. According to the study, dosage should be individualized in order to optimize the treatment based on the measurement of theophylline concentration in plasma. |
format | Online Article Text |
id | pubmed-4877906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Institute of Immunobiology and Human Genetics |
record_format | MEDLINE/PubMed |
spelling | pubmed-48779062016-06-06 Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma Goseva, Zlatica Gjorcev, Angelko Kaeva, Biserka Jovkovska Janeva, Elena Jovanovska Angelovska, Irina Open Access Maced J Med Sci Clinical Science BACKGROUND: While dosing theophylline in asthmatics, we should consider that a lot of medicines, substances, conditions and diseases affect the clearance of theophylline, such as smoking, macrolide antibiotics, barbiturates, oral contraceptives, heart and liver insufficiency, alcohol, calcium-antagonists, pneumonia, viral infections, hypoxemia, etc. AIM: The aim of the study is to investigate the concentrations of theophylline during the day in smoking and nonsmoking patients with asthma. MATERIAL AND METHODS: We have estimated the concentrations of theophylline 6 times daily by the HPLC method (Keith Muir, J Chromatography) in 20 smoking and 20 nonsmoking asthmatic patients, who were treated with theophylline sustained-release tablets 175 mg twice daily. RESULTS: In the first group of 20 nonsmoking patients we obtained constant therapeutic and optimal concentrations of theophylline. In the second group of 20 smoking asthmatics the concentration of theophylline in plasma, in 8pm and 8am the next day was very low. CONCLUSION: Because in smokers we have increased clearance and the decreased half- life of theophylline, and in order to prevent the night time life-threatening attacks, it is necessary to recommend maximal doses of theophylline, especially in the evening. According to the study, dosage should be individualized in order to optimize the treatment based on the measurement of theophylline concentration in plasma. Institute of Immunobiology and Human Genetics 2015-12-15 2015-11-14 /pmc/articles/PMC4877906/ /pubmed/27275306 http://dx.doi.org/10.3889/oamjms.2015.117 Text en Copyright: © 2015 Zlatica Goseva, Angelko Gjorcev, Biserka Jovkovska Kaeva, Elena Jovanovska Janeva, Irina Angelovska. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Clinical Science Goseva, Zlatica Gjorcev, Angelko Kaeva, Biserka Jovkovska Janeva, Elena Jovanovska Angelovska, Irina Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma |
title | Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma |
title_full | Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma |
title_fullStr | Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma |
title_full_unstemmed | Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma |
title_short | Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma |
title_sort | analysis of plasma concentrations of theophylline in smoking and nonsmoking patients with asthma |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877906/ https://www.ncbi.nlm.nih.gov/pubmed/27275306 http://dx.doi.org/10.3889/oamjms.2015.117 |
work_keys_str_mv | AT gosevazlatica analysisofplasmaconcentrationsoftheophyllineinsmokingandnonsmokingpatientswithasthma AT gjorcevangelko analysisofplasmaconcentrationsoftheophyllineinsmokingandnonsmokingpatientswithasthma AT kaevabiserkajovkovska analysisofplasmaconcentrationsoftheophyllineinsmokingandnonsmokingpatientswithasthma AT janevaelenajovanovska analysisofplasmaconcentrationsoftheophyllineinsmokingandnonsmokingpatientswithasthma AT angelovskairina analysisofplasmaconcentrationsoftheophyllineinsmokingandnonsmokingpatientswithasthma |